Table 2.

Dysregulated miRNAs in Pulmonary Hypertension Organized by Their Mechanistic Role

Mechanism	miRNA
Proliferation	miR-210; miR-204; miR-424; miR-503; miR-130/301; miR-193; miR-17∼92; miR-145; miR-21; miR-124; miR-140; miR-500b-3p; miR-206; miR-200; miR-338-3p; miR-141-3p; miR-133a-3p: miR-29a; miR-214; miR-223; miR-100; miR-222; miR-25; miR-138; miR-1; miR-497, miR-1268, miR-665; miR-98; miR-191; miR-30a-5p; miR-593-5p; miR-203; miR-429; miR-371b-5p; miR-760; miR-1181; miR-143; miR-92b-3p; miR-135a-5p; miR-23a; miR-1281; miR-361-5p; miR-195-5p; miR-150; miR-4632; miR-221-3p; miR-125; miR-34; miR-103/107 miR-322: miR-199b-5p; let-7a-5p; miR-20a; miR-328
Vasoconstriction	miR-130/301; miR-328; miR-190; miR-29b; miR-1; miR-543; miR-27b; mR-328
DNA damage	miR-223; miR-204
Estrogen signaling and sex-specific	miR-96; miR-29
Angiogenesis	miR-208; miR-126; miR-495 miR-206
Inflammation	miR-181a/b-5p; miR-146b; miR-135; miR-124

Abbreviation as in Table 1.